Patients randomized to the fever prevention group will have ArcticGel Pads placed on their body. These will be connected to the Arctic Sun System. The system will be programmed to keep the patient's body temperature at 98.6. Treatment will last for 14 days or until ready to be discharged from the ICU. Standard of care patients will receive standard medical care as prescribed by the medical team.More
Adult, primary diagnosis of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
University of Colorado Hospital
Luis Cava Prado, MD
Protocol Number: 18-0548
More information available at ClinicalTrials.gov: NCT02996266
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers